In humans, IL10 treatment normalizes serum ALT level, improves liver histology and reduces liver fibrosis in patients with chronic hepatitis C 53, and the high IL10 production haplotype of its gene promoter is associated with reduced susceptibility to liver cirrhosis 54. The gene discussed is GPT; the disease is Hepatic fibrosis.